Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot B Tapper

Showing results (321-330 of 349) with videos related to

Pageof 35
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2018
A Multicenter Study Into Causes of Severe Acute Liver InjuryAnthony C Breu, Vilas R Patwardhan, Jennifer Nayor, et al.
JAMA Network Open|September 2, 2020
Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C CirrhosisGeorge N Ioannou, Weijing Tang, Lauren A Beste, et al.
The Lancet. Gastroenterology & Hepatology|September 13, 2024
Global differences in the management of alcohol-associated hepatitisHanna Blaney, Luis Antonio Díaz, Nhi Li, et al.
The American Journal of Gastroenterology|August 9, 2024
Patients With Cirrhosis Rapidly Review Potentially Abnormal Hepatocellular Carcinoma Surveillance Results Through the Patient PortalJeremy Louissaint, Beverly Kyalwazi, John Deng, et al.
The American Journal of Gastroenterology|June 11, 2025
Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver diseaseA Sidney Barritt, Elliot B Tapper, Philip N Newsome, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2021
Patient Preferences for Hepatocellular Carcinoma Surveillance ParametersSean A Woolen, Amit G Singal, Matthew S Davenport, et al.
Gastroenterology|July 30, 2019
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 ScoresGeorge N Ioannou, Lauren A Beste, Pamela K Green, et al.
Hepatology (Baltimore, Md.)|August 4, 2012
Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null miceXiaofeng Sun, Lihui Han, Pankaj Seth, et al.
The American Journal of Gastroenterology|July 4, 2020
Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN ConsensusJasmohan S Bajaj, Mette Lauridsen, Elliot B Tapper, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort studyElliot B Tapper, Bruce R Bacon, Michael P Curry, et al.
Pageof 35

Showing results (321-330 of 349) with videos related to

Sort By:
Pageof 35
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2018
A Multicenter Study Into Causes of Severe Acute Liver InjuryAnthony C Breu, Vilas R Patwardhan, Jennifer Nayor, et al.
JAMA Network Open|September 2, 2020
Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C CirrhosisGeorge N Ioannou, Weijing Tang, Lauren A Beste, et al.
The Lancet. Gastroenterology & Hepatology|September 13, 2024
Global differences in the management of alcohol-associated hepatitisHanna Blaney, Luis Antonio Díaz, Nhi Li, et al.
The American Journal of Gastroenterology|August 9, 2024
Patients With Cirrhosis Rapidly Review Potentially Abnormal Hepatocellular Carcinoma Surveillance Results Through the Patient PortalJeremy Louissaint, Beverly Kyalwazi, John Deng, et al.
The American Journal of Gastroenterology|June 11, 2025
Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver diseaseA Sidney Barritt, Elliot B Tapper, Philip N Newsome, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2021
Patient Preferences for Hepatocellular Carcinoma Surveillance ParametersSean A Woolen, Amit G Singal, Matthew S Davenport, et al.
Gastroenterology|July 30, 2019
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 ScoresGeorge N Ioannou, Lauren A Beste, Pamela K Green, et al.
Hepatology (Baltimore, Md.)|August 4, 2012
Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null miceXiaofeng Sun, Lihui Han, Pankaj Seth, et al.
The American Journal of Gastroenterology|July 4, 2020
Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN ConsensusJasmohan S Bajaj, Mette Lauridsen, Elliot B Tapper, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort studyElliot B Tapper, Bruce R Bacon, Michael P Curry, et al.
Pageof 35